Status:
UNKNOWN
High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors
Lead Sponsor:
Peking University Third Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18-75 years
Brief Summary
This is a single-center study.Eligible patients will have histologically proven pelvic recurrence of cervical cancer after radiotherapy .
Detailed Description
The results of treatment, examination and follow-up of patients with recurrent cervical cancer after radiotherapy who recieved imaging guided three dimensional printing personalized template assisted ...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed pelvic recurrence of cervical cancer.
- Age ≥ 18 years and ≤ 75 years.
- Previous accept pelvic radiotherapy;
- Karnofsky ≥60；
- Patients reject or cannot tolerate surgery;
- Received 192Ir high dose rate intertissue salvage therapy;
- Ultrasound guidance or computed tomography guidance;
- Regular review and follow-up.
Exclusion
- Patients participated in clinical trials of other drugs within four weeks;
- The patient had a previous history of bleeding, and any bleeding event with severity rating of CTCAE5.0 or above occurred within 4 weeks prior to screening;
- There are any puncture taboos.
- Patients with severe cardiovascular and cerebrovascular diseases.
- Unable to treat as planned.
- Patients lack major indicators and cannot participate in post-treatment review and follow-up.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04127435
Start Date
January 1 2019
End Date
December 31 2020
Last Update
October 15 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China
2
Peking University Third Hospital
Beijing, China